Skip to main
We’re doing some system maintenance
  1. Home
  2. Stocks
  3. Loxo Oncology
LOXO

Buy Loxo Oncology (LOXO) Stock

LOXO
See LOXO stock price and Buy/Sell Loxo Oncology with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing
LOXO

Loxo Oncology (LOXO)

We couldn’t load this chart.

Some stock charts might currently not be supported. To try again, please refresh this page.

About Loxo Oncology (LOXO)

Loxo Oncology was incorporated in Delaware in May 2013 and was founded by Josh Bilenker, M.D., a partner at Aisling Capital. Loxo Oncology is committed to bringing targeted cancer therapies rapidly into the clinic that have an opportunity for outsized clinical effects in genetically defined patient populations. Loxo Oncology derives its company name from an attendant of the Greek goddess Artemis, ...Read more
Market Cap
$7.18B
1 Year High
$234.93
Volume
1 Year Low
$103.50
Price to Earnings Ratio
Open
Dividend Rate
High
Dividend Yield
Low

Community

People who own or watch LOXO stock

Loxo Oncology stock rating

What analysts recommend for LOXO stock, on a scale from 1 (buy) to 5 (sell).
Buy
Sell
3

Loxo Oncology price target

What analysts think LOXO will be worth
Low $0
High $235
Current $0
Target $235

Loxo Oncology earnings

The value each share was expected to gain vs. the value that each share actually gained
0.41
-0.04
-0.49
-0.93
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Q4 2019

Expected EPS
Q4 2019
-$0.60
Actual EPS
Q4 2019

Buy Loxo Oncology (LOXO) Stock

LOXO
See LOXO stock price and Buy/Sell Loxo Oncology with any amount of money. Discuss news and analysts' price predictions with the investor community.
Sign up to start investing

Community

People who own or watch LOXO stock
  • papas702 avatar
  • jordanlehocky avatar
  • kimmyandco avatar
Check the background of this firm on FINRA’s BrokerCheck.

© Copyright 2022 Public Holdings, Inc. All Rights Reserved.

Securities are offered to self-directed customers by Open to the Public Investing, Inc. (“Open to the Public Investing”), a registered broker-dealer and member of FINRA & SIPC. Additional information about your broker can be found by clicking here. Open to Public Investing is a wholly-owned subsidiary of Public Holdings Inc. (“Public Holdings”). This is not an offer, solicitation of an offer or advice to buy or sell securities, or open a brokerage account in any jurisdiction where Open to the Public Investing is not registered. Securities products offered by Open to the Public Investing are not FDIC insured.

Cryptocurrency execution and custody services are provided by Apex Crypto LLC (NMLS ID 1828849) through a software licensing agreement between Apex Crypto LLC and Public Crypto LLC. Apex Crypto is not a registered broker-dealer or a member of SIPC or FINRA. Cryptocurrencies are not securities and are not FDIC or SIPC insured. Apex Crypto is licensed to engage in virtual currency business activity by the New York State Department of Financial Services. Please ensure that you fully understand the risks involved before trading: Legal Disclosures

Commission-free trading of stocks and ETFs refers to $0 commissions for Open to the Public Investing self-directed individual cash brokerage accounts that trade the U.S. listed securities electronically. Keep in mind, that other fees such as regulatory fees, Premium subscription fees, wire transfer fees, and paper statement fees may apply to your brokerage account. Please see Open to the Public Investing’s Fee Schedule to learn more.

All investments involve the risk of loss and the past performance of a security or a financial product does not guarantee future results or returns.